Want to see HK:0157 full AI Analyst Report?
Natural Beauty Bio-Technology (0157) AI Stock Analysis
Natural Beauty Bio-Technology
(HKEX:0157)
Weak cash flows and inconsistent profitability drag down financial performance; neutral technicals and high valuation add caution.
Natural Beauty Bio-Technology (0157) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 100.11M
- Dividend Yield
- ―
- Average Volume (3M)
- 114.28K
- Price to Earnings (P/E)
- -15.3
- Beta (1Y)
- -0.04
- Revenue Growth
- 13.43%
- EPS Growth
- 7.72%
- Country
- Hong Kong
- Employees
- 597
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
Natural Beauty Bio-Technology Business Overview & Revenue Model
Company Description
Natural Beauty Bio-Technology Limited operates as an investment holding company, supplying skincare products and a comprehensive range of services across the People's Republic of China, Taiwan, and other global regions. Under its "Natural Beauty" bra...
How the Company Makes Money
null
Natural Beauty Bio-Technology Financial Statement Overview
Summary
Mixed financials with revenue growth and return to profitability, but weak margins, rising debt, and negative cash flows indicate operational challenges.
Income Statement
45NeutralBalance Sheet
55NeutralCash Flow
30Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 523.38M | 538.83M | 353.65M | 336.01M | 335.88M | 487.81M |
| Gross Profit | 227.26M | 293.34M | 202.33M | 200.34M | 165.33M | 281.80M |
| EBITDA | 4.98M | 66.15M | -65.50M | 22.91M | 15.09M | 85.23M |
| Net Income | -57.48M | 10.58M | -103.61M | -15.11M | -30.47M | 35.26M |
Balance Sheet | ||||||
| Total Assets | 1.01B | 931.55M | 772.93M | 882.58M | 883.53M | 937.16M |
| Cash, Cash Equivalents and Short-Term Investments | 116.16M | 112.12M | 116.51M | 166.81M | 168.61M | 197.08M |
| Total Debt | 424.66M | 319.30M | 212.13M | 186.29M | 143.48M | 129.07M |
| Total Liabilities | 587.05M | 457.56M | 325.34M | 308.06M | 286.07M | 279.24M |
| Stockholders Equity | 423.52M | 473.98M | 447.59M | 574.52M | 597.46M | 657.92M |
Cash Flow | ||||||
| Free Cash Flow | -136.88M | -93.91M | -54.96M | -47.39M | -35.98M | 4.67M |
| Operating Cash Flow | -58.33M | -25.66M | -13.75M | 21.72M | 8.33M | 42.78M |
| Investing Cash Flow | -74.73M | -68.95M | -40.17M | -67.61M | -38.77M | -31.21M |
| Financing Cash Flow | 169.03M | 84.61M | 15.34M | 42.63M | 13.21M | 10.42M |
Natural Beauty Bio-Technology Peers Comparison
Overall Rating
HK:214571Outperform
HK:104468Neutral
HK:382866Neutral- HK:015746Neutral
HK:699333Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2145 | 71Outperform | HKD 9.03B | 11.18 | 25.77% | 6.20% | 23.19% | -22.44% |
| HK:1044 | 68Neutral | HKD 24.47B | 8.46 | 10.98% | 7.60% | 2.19% | 10.78% |
| HK:3828 | 66Neutral | HKD 484.68M | 5.70 | 6.06% | 9.77% | 2.24% | -39.98% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| HK:0157 | 46Neutral | HKD 880.92M | -15.33 | -12.81% | ― | 13.43% | 7.72% |
| HK:6993 | 33Underperform | HKD 13.52B | -148.17 | -1.21% | 6.58% | -2.44% | 81.73% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0157 | Natural Beauty Bio-Technology | 0.44 | -0.10 | -18.52% | |
| HK:1044 | Hengan International Group Co | 21.08 | -4.88 | -18.80% | |
| HK:3828 | Ming Fai International Holdings | 0.67 | -0.23 | -25.36% | |
| HK:2145 | Shanghai Chicmax Cosmetics Co., Ltd. Class H | 22.66 | -60.79 | -72.85% | |
| HK:6993 | Blue Moon Group Holdings Ltd. | 2.43 | -0.36 | -13.03% | |
| HK:6883 | Eternal Beauty Holdings Limited | 2.03 | 0.06 | 3.05% |
Natural Beauty Bio-Technology Corporate Events
Natural Beauty Bio-Technology calls EGM to approve new multi-year cooperation deals
Natural Beauty Bio-Technology has convened an extraordinary general meeting in Taipei on 24 August 2026 to seek shareholder approval for three major cooperation and supply agreements running from 1 September 2026 to 31 August 2029. The ET New Media C...
Natural Beauty Bio-Technology Further Delays Circular on Connected Transactions
Natural Beauty Bio-Technology Limited has announced a further delay in sending a shareholder circular related to the renewal of its continuing connected transactions. The company had previously indicated the circular would be dispatched by 27 July 20...
Natural Beauty Bio-Technology warns of first-half loss amid expansion costs
Natural Beauty Bio-Technology has warned that it expects to swing to a net loss of about HK$56 million to HK$59 million for the first half of 2026, compared with a net profit of HK$10.9 million a year earlier. The deterioration reflects a 5.84% drop...
Natural Beauty Bio-Technology Sets August Board Meeting on Interim Results and Dividend
Natural Beauty Bio-Technology Limited has scheduled a board meeting for 6 August 2026 to review and approve the group’s interim results for the six months ended 30 June 2026. The board will also consider the payment of an interim dividend, if a...
Natural Beauty Bio-Technology Delays Circular on Connected Transactions
Natural Beauty Bio-Technology Limited has announced a delay in sending a shareholder circular related to the renewal of its continuing connected transactions. The circular, initially expected to be despatched by 6 July 2026, will now be sent on or be...
Natural Beauty Bio-Technology Wins Unanimous Shareholder Backing at AGM
Natural Beauty Bio-Technology reported that all resolutions at its 25 June 2026 annual general meeting were passed by poll with 100% support from voting shareholders. The meeting approved the 2025 audited financial statements, re-elected the full sla...
Natural Beauty Renews Connected Deals, Triggers Shareholder Vote Under HK Rules
Natural Beauty Bio-Technology has renewed a series of continuing connected transaction agreements between its subsidiaries Taiwan NB and NB China and several related parties, including ET New Media, Eastern Home, Eastern Global, ET New Retail and Str...
Natural Beauty Bio-Technology Sets AGM to Approve Accounts, Board and Share Buy-Back Mandate
Natural Beauty Bio-Technology has called its annual general meeting for 25 June 2026 in Taipei, where shareholders will review the group’s audited consolidated financial statements and the board and auditor reports for the year ended 31 Decembe...
Natural Beauty Bio-Technology Strengthens Board to Meet Governance Rules
Natural Beauty Bio-Technology has strengthened its board by appointing veteran Taiwanese public servant and corporate director Mr. Duh Tyzz-Jiun as an independent non-executive director, effective 25 May 2026. He will also sit on the audit and nomina...
Natural Beauty Bio-Technology Reshapes Board and Committee Structure
Natural Beauty Bio-Technology has updated the composition of its board of directors with effect from 25 May 2026, naming Dr. Lei Chien as chairperson alongside executive, non-executive, and independent non-executive directors. The company also detail...
Natural Beauty Bio-Technology Reshapes Board and Committee Roles
Natural Beauty Bio-Technology Limited has updated the composition of its board of directors effective 16 May 2026, naming Dr. Lei Chien as chairperson and confirming a mix of executive, non-executive, and independent non-executive directors. The comp...
Natural Beauty Bio-Technology Announces Board Reshuffle and Confirms Governance Compliance
Natural Beauty Bio-Technology announced that executive director Mr. Lin Chia-Wei will resign on 16 May 2026 from the board, its nomination, remuneration and executive committees, and his role as authorised representative, citing the need to focus on...
Natural Beauty Bio-Technology Faces Governance Gap After Independent Director Exit
Natural Beauty Bio-Technology Limited announced that independent non-executive director Mr. Chen Ruey-Long has resigned, effective 8 May 2026, stepping down as chairman of the Audit Committee and as a member of the Nomination and Remuneration Committ...
Natural Beauty Bio-Technology Updates Board and Committee Structure
Natural Beauty Bio-Technology Limited has outlined the current composition of its board, naming Dr. Lei Chien as chairperson alongside executive, non-executive and independent non-executive directors, reflecting a diversified governance structure. Th...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 06, 2026